Last reviewed · How we verify
VISION5 Product
At a glance
| Generic name | VISION5 Product |
|---|---|
| Sponsor | ForSight Vision5, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product (PHASE2)
- A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- VISION5 Product CI brief — competitive landscape report
- VISION5 Product updates RSS · CI watch RSS
- ForSight Vision5, Inc. portfolio CI